291 related articles for article (PubMed ID: 24856668)
1. Extended pancreatectomy in pancreatic ductal adenocarcinoma: definition and consensus of the International Study Group for Pancreatic Surgery (ISGPS).
Hartwig W; Vollmer CM; Fingerhut A; Yeo CJ; Neoptolemos JP; Adham M; Andrén-Sandberg A; Asbun HJ; Bassi C; Bockhorn M; Charnley R; Conlon KC; Dervenis C; Fernandez-Cruz L; Friess H; Gouma DJ; Imrie CW; Lillemoe KD; Milićević MN; Montorsi M; Shrikhande SV; Vashist YK; Izbicki JR; Büchler MW;
Surgery; 2014 Jul; 156(1):1-14. PubMed ID: 24856668
[TBL] [Abstract][Full Text] [Related]
2. Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer.
Hartwig W; Gluth A; Hinz U; Koliogiannis D; Strobel O; Hackert T; Werner J; Büchler MW
Br J Surg; 2016 Nov; 103(12):1683-1694. PubMed ID: 27686238
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
[TBL] [Abstract][Full Text] [Related]
4. Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors.
Mitra A; Pai E; Dusane R; Ranganathan P; DeSouza A; Goel M; Shrikhande SV
Langenbecks Arch Surg; 2018 Mar; 403(2):203-212. PubMed ID: 29362882
[TBL] [Abstract][Full Text] [Related]
5. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
[TBL] [Abstract][Full Text] [Related]
7. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
8. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
[TBL] [Abstract][Full Text] [Related]
9. Survival impact of distal pancreatectomy with en bloc celiac axis resection combined with neoadjuvant chemotherapy for borderline resectable or locally advanced pancreatic body carcinoma.
Murakami Y; Nakagawa N; Kondo N; Hashimoto Y; Okada K; Seo S; Otsuka H
Pancreatology; 2021 Apr; 21(3):564-572. PubMed ID: 33526385
[TBL] [Abstract][Full Text] [Related]
10. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
11. Arterial resection during pancreatectomy for pancreatic ductal adenocarcinoma with arterial invasion: A single-center experience with 109 patients.
Kwon J; Shin SH; Yoo D; Hong S; Lee JW; Youn WY; Hwang K; Lee SJ; Park G; Park Y; Lee W; Song KB; Lee JH; Hwang DW; Kim SC
Medicine (Baltimore); 2020 Sep; 99(37):e22115. PubMed ID: 32925757
[TBL] [Abstract][Full Text] [Related]
12. Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.
Kang CM; Kim DH; Choi GH; Kim KS; Choi JS; Lee WJ
J Gastrointest Surg; 2009 May; 13(5):907-14. PubMed ID: 19224295
[TBL] [Abstract][Full Text] [Related]
13. A single center experience in resectable pancreatic ductal adenocarcinoma : the limitations of the surgery-first approach. Critical review of the literature and proposals for practice update.
Dumont R; Puleo F; Collignon J; Meurisse N; Chavez M; Seidel L; Gast P; Polus M; Loly C; Delvenne P; Meunier P; Hustinx R; Deroover A; Detry O; Louis E; Martinive P; Van Daele D
Acta Gastroenterol Belg; 2017; 80(4):451-461. PubMed ID: 29560639
[TBL] [Abstract][Full Text] [Related]
14. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
Bockhorn M; Uzunoglu FG; Adham M; Imrie C; Milicevic M; Sandberg AA; Asbun HJ; Bassi C; Büchler M; Charnley RM; Conlon K; Cruz LF; Dervenis C; Fingerhutt A; Friess H; Gouma DJ; Hartwig W; Lillemoe KD; Montorsi M; Neoptolemos JP; Shrikhande SV; Takaori K; Traverso W; Vashist YK; Vollmer C; Yeo CJ; Izbicki JR;
Surgery; 2014 Jun; 155(6):977-88. PubMed ID: 24856119
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic versus open pancreatic resection for ductal adenocarcinoma: separate propensity score matching analyses of distal pancreatectomy and pancreaticoduodenectomy.
Chen K; Pan Y; Huang CJ; Chen QL; Zhang RC; Zhang MZ; Wang GY; Wang XF; Mou YP; Yan JF
BMC Cancer; 2021 Apr; 21(1):382. PubMed ID: 33836678
[TBL] [Abstract][Full Text] [Related]
16. Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
Truty MJ; Kendrick ML; Nagorney DM; Smoot RL; Cleary SP; Graham RP; Goenka AH; Hallemeier CL; Haddock MG; Harmsen WS; Mahipal A; McWilliams RR; Halfdanarson TR; Grothey AF
Ann Surg; 2021 Feb; 273(2):341-349. PubMed ID: 30946090
[TBL] [Abstract][Full Text] [Related]
17. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS).
Tol JA; Gouma DJ; Bassi C; Dervenis C; Montorsi M; Adham M; Andrén-Sandberg A; Asbun HJ; Bockhorn M; Büchler MW; Conlon KC; Fernández-Cruz L; Fingerhut A; Friess H; Hartwig W; Izbicki JR; Lillemoe KD; Milicevic MN; Neoptolemos JP; Shrikhande SV; Vollmer CM; Yeo CJ; Charnley RM;
Surgery; 2014 Sep; 156(3):591-600. PubMed ID: 25061003
[TBL] [Abstract][Full Text] [Related]
18. Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas.
Takahashi Y; Kaneoka Y; Maeda A; Isogai M
World J Surg; 2011 Nov; 35(11):2535-42. PubMed ID: 21901326
[TBL] [Abstract][Full Text] [Related]
19. [New aspects of surgery for pancreatic cancer. Principles, results and evidence].
Distler M; Grützmann R
Pathologe; 2012 Nov; 33 Suppl 2():258-65. PubMed ID: 23108784
[TBL] [Abstract][Full Text] [Related]
20. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
